# 68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study

> **NCT06688188** · EARLY_PHASE1 · RECRUITING · sponsor: **First Affiliated Hospital of Fujian Medical University** · enrollment: 5 (estimated)

## Conditions studied

- Malignant Neoplasm

## Interventions

- **DRUG:** 68Ga-JH12

## Key facts

- **NCT ID:** NCT06688188
- **Lead sponsor:** First Affiliated Hospital of Fujian Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06688188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06688188, "68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06688188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*